These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 31999896)

  • 1. Kratom (Mitragyna speciosa): Friend or Foe?
    Sethi R; Hoang N; Ravishankar DA; McCracken M; Manzardo AM
    Prim Care Companion CNS Disord; 2020 Jan; 22(1):. PubMed ID: 31999896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns and reasons for kratom (Mitragyna speciosa) use among current and former opioid poly-drug users.
    Singh D; Yeou Chear NJ; Narayanan S; Leon F; Sharma A; McCurdy CR; Avery BA; Balasingam V
    J Ethnopharmacol; 2020 Mar; 249():112462. PubMed ID: 31816368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Pharmacology of the Dietary Supplement Kratom (Mitragyna speciosa).
    Hartley C; Bulloch M; Penzak SR
    J Clin Pharmacol; 2022 May; 62(5):577-593. PubMed ID: 34775626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology of kratom: an emerging botanical agent with stimulant, analgesic and opioid-like effects.
    Prozialeck WC; Jivan JK; Andurkar SV
    J Am Osteopath Assoc; 2012 Dec; 112(12):792-9. PubMed ID: 23212430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Case Report of Kratom Addiction and Withdrawal.
    Galbis-Reig D
    WMJ; 2016 Feb; 115(1):49-52; quiz 53. PubMed ID: 27057581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on the Pharmacology and Legal Status of Kratom.
    Prozialeck WC
    J Am Osteopath Assoc; 2016 Dec; 116(12):802-809. PubMed ID: 27893147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic and clinical assessment of kratom: An update.
    White CM
    Am J Health Syst Pharm; 2019 Nov; 76(23):1915-1925. PubMed ID: 31626272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kratom (Mitragyna speciosa): A Case Review of Use Before and During Pregnancy.
    Faucher MA; Morillos S; Cordova P; McNeil-Santiel J; Onisko N; Adhikari EH; Nelson DB
    J Midwifery Womens Health; 2024; 69(1):144-149. PubMed ID: 37679866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kratom: Substance of Abuse or Therapeutic Plant?
    Gorelick DA
    Psychiatr Clin North Am; 2022 Sep; 45(3):415-430. PubMed ID: 36055730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Complex Case of Kratom Dependence, Depression, and Chronic Pain in Opioid Use Disorder: Effects of Buprenorphine in Clinical Management.
    Bowe A; Kerr PL
    J Psychoactive Drugs; 2020; 52(5):447-452. PubMed ID: 32546067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kratom: Implications for Health Care Providers.
    Goldin D; Salani D; Mckay M
    J Psychosoc Nurs Ment Health Serv; 2019 Dec; 57(12):15-20. PubMed ID: 31774129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kratom and opioid use disorder in the perioperative period: A case report on the expanding role of buprenorphine.
    Perez J
    J Opioid Manag; 2023; 19(1):91-93. PubMed ID: 36683304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Kratom Dependence With Buprenorphine-Naloxone Maintenance.
    Buresh M
    J Addict Med; 2018; 12(6):481-483. PubMed ID: 29944481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the therapeutic potential and toxicity of
    Sharma A; McCurdy CR
    Expert Opin Drug Metab Toxicol; 2021 Mar; 17(3):255-257. PubMed ID: 33213215
    [No Abstract]   [Full Text] [Related]  

  • 15. The therapeutic potential of kratom.
    Grundmann O; Brown PN; Henningfield J; Swogger M; Walsh Z
    Addiction; 2018 Oct; 113(10):1951-1953. PubMed ID: 29949213
    [No Abstract]   [Full Text] [Related]  

  • 16. Mini review: Potential therapeutic values of mitragynine as an opioid substitution therapy.
    Harun N; Kamaruzaman NA; Mohamed Sofian Z; Hassan Z
    Neurosci Lett; 2022 Mar; 773():136500. PubMed ID: 35114335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-treatment of opioid withdrawal using kratom (Mitragynia speciosa korth).
    Boyer EW; Babu KM; Adkins JE; McCurdy CR; Halpern JH
    Addiction; 2008 Jun; 103(6):1048-50. PubMed ID: 18482427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kratom Withdrawal: A Systematic Review with Case Series.
    Stanciu CN; Gnanasegaram SA; Ahmed S; Penders T
    J Psychoactive Drugs; 2019; 51(1):12-18. PubMed ID: 30614408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An update on the clinical pharmacology of kratom: uses, abuse potential, and future considerations.
    McCurdy CR; Sharma A; Smith KE; Veltri CA; Weiss ST; White CM; Grundmann O
    Expert Rev Clin Pharmacol; 2024; 17(2):131-142. PubMed ID: 38217374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural drugs, not so natural effects: Neonatal abstinence syndrome secondary to 'kratom'.
    Davidson L; Rawat M; Stojanovski S; Chandrasekharan P
    J Neonatal Perinatal Med; 2019; 12(1):109-112. PubMed ID: 30149482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.